Skip to main content

Alfresa s Value Stock - Dividend - Research Selection

Alfresa Holdings Corporation

ISIN: JP3126340003, WKN: 912620

Market price date: 21.01.2022
Market price: 1.595,00 JPY


Alfresa Holdings Corporation Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 21-10-2021
Cash flow
Net operating cash flow -21.191.000.000
Capital Expenditures -15.054.000.000
Free cash flow -36.245.000.192
Balance sheet
Total Equity 489.736.000.000
Liabilities & Shareholders equity 1.316.660.000.000
Income statement
Net income 24.501.000.000
Eps (diluted) 115,749
Diluted shares outstanding 211.674.000
Net sales/revenue 2.603.260.000.000

Fundamental ratios calculated on: 21-01-2022

Ratios
Key figures 21-01-2022
Cash flow
P/C -15,93
   
P/FC -9,32
Balance sheet
ROI1,86
ROE37,20
Income statement
P/E13,78
Div. Yield3,32%
P/B0,69
P/S0,13


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol2784.TSE
Market Capitalization3.255.047.424,00 USD
CountryJapan
IndicesMSCI World Index
SectorsHealth Care Distributors
Raw Data SourceIFRS in Millionen JPY
Stock Split2014-09-26,4.000000/1.000000
Internetwww.alfresa.com


Description of the company

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.alfresa.com


NEWS